Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: A phase I clinical study Article

Schulz, CA, Mehta, MP, Badie, B et al. (2004). Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: A phase I clinical study . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 59(4), 1107-1115. 10.1016/j.ijrobp.2003.12.007

cited authors

  • Schulz, CA; Mehta, MP; Badie, B; McGinn, CJ; Robins, HI; Hayes, L; Chappell, R; Volkman, J; Binger, K; Arzoomanian, R; Simon, K; Alberti, D; Feierabend, C; Tutsch, KD; Kunugi, KA; Wilding, G; Kinsella, TJ

sustainable development goals

authors

publication date

  • July 15, 2004

webpage

published in

keywords

  • ANAPLASTIC ASTROCYTOMA
  • CELLULAR DNA
  • COLON CANCER-CELLS
  • CONTINUOUS INTRAVENOUS INFUSIONS
  • DNA INCORPORATION
  • GLIOBLASTOMA-MULTIFORME
  • HALOGENATED PYRIMIDINES
  • LINEAR QUADRATIC ANALYSIS
  • Life Sciences & Biomedicine
  • Oncology
  • RADIATION-THERAPY
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • THYMIDINE REPLACEMENT
  • hyperfractionated accelerated radiotherapy
  • iododeoxyuridine
  • malignant glioma
  • phase I

Location

  • NEW ORLEANS, LA

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1107

end page

  • 1115

volume

  • 59

issue

  • 4